| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Russel C Robertson is Director at BHC, with reported holdings spanning 2 companies. Russel C Robertson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.7M at current prices.
Russel C Robertson's largest disclosed position is in BLCO as Director, worth about $1.9M. Net of sales, the BLCO filings show accumulation of 4,400 shares.
Russel C Robertson has 59 Form 4 filings on record from June 2016 to October 2026, across 2 companies: Director at Bausch + Lomb (BLCO), 2022–2026; Director at Bausch Health Companies (BHC), 2016–2024.
The 60 reported transactions were 58 stock awards, 1 open-market purchase and 1 tax withholding.
Counted by filing, the open-market trades come to 1 purchase worth about $79K and no sales.
The only open-market purchase was 4,400 shares of BLCO at an average $17.90 on February 20, 2026, about $79K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | BLCO Bausch + Lomb Corporation | Director | Buy | 4,400 | $17.90 | $78,760.00 | +6.5% | -10.0% | - |